PharmaCyte Biotech, Inc.

PMCB · NASDAQ
Analyze with AI
7/31/2025
4/30/2025
1/31/2025
10/31/2024
Assets
Cash & Equivalents$13,178$15,172$16,383$20,840
Short-Term Investments$262$366$373$0
Receivables$4,608$3,696$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,058$3,141$207$493
Total Curr. Assets$19,106$22,375$16,963$21,333
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$1,549$1,549$1,549$1,549
Long-Term Investments$24,447$22,474$25,308$24,855
Tax Assets$0$0$0$0
Other NC Assets$8$8,770$8$7,361
Total NC Assets$26,004$32,793$26,865$33,765
Other Assets$0$0$0$0
Total Assets$45,110$55,168$43,829$55,098
Liabilities
Payables$465$399$485$349
Short-Term Debt$0$0$0$0
Tax Payable$0$0$364$362
Deferred Revenue$0$0$0$0
Other Curr. Liab.$596$2,515$346$4,066
Total Curr. Liab.$1,061$2,914$1,194$4,776
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$458$363$2,384$6,871
Total NC Liab.$458$363$2,384$6,871
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$1,519$3,277$3,578$11,647
Equity
Pref Stock$0$0$0$0
Common Stock$2$2$2$2
Retained Earnings-$93,329-$84,969-$96,719-$93,673
AOCI-$24-$24-$24-$23
Other Equity$136,942$136,882$136,991$137,145
Total Equity$43,592$51,891$40,250$43,451
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$45,110$55,168$43,829$55,098
Net Debt-$13,178-$15,172-$16,383-$20,840